Tag: Vertex

As markets experienced volatility in September, heavyweight investors demonstrated significant conviction in Vertex Pharmaceuticals. Both institutional players and corporate insiders ...

Vertex Pharmaceuticals presents investors with a compelling puzzle. The biotechnology giant continues to deliver robust financial performance and clinical breakthroughs, ...

Despite posting strong Q2 earnings, Vertex Pharmaceuticals faced a 9% stock drop as clinical setbacks in its pain therapy pipeline ...